by Smriti Haria | Jul 13, 2021 | Alzheimer's Disease, Medical Officers
As of 2016, 50 million people worldwide had received a diagnosis of Alzheimer’s Disease (AD) [1]. For this vast number, the neurodegenerative component of the condition is unfortunately not the only significant consequence. Preliminary research had suggested a link... 
by Sharen Singh | Jun 30, 2021 | Alzheimer's Disease, I. Issues
More than 25 million people in the world today are affected by dementia, most suffering from Alzheimer’s disease. In both developed and developing nations, Alzheimer’s disease (AD) has had a tremendous impact on the affected individuals, caregivers, and... 
by Sharen Singh | Jun 3, 2021 | Alzheimer's Disease, I. Issues, II. Roles, Medical Officers
Increasing evidence suggests that Alzheimer’s disease pathogenesis is not restricted to the neuronal compartment, but includes strong interactions with immunological mechanisms in the brain. Misfolded and aggregated proteins bind to pattern recognition receptors... 
by Marina Norfolk | May 31, 2021 | Alzheimer's Disease, Medical Officers
Alzheimer’s disease (AD) is a chronic neurodegenerative disease that leads to gradual loss of function in motor skills and cognitive function of patients. As the most common type of dementia, Alzheimer’s impacts over 5 million Americans who are 65 and older, and this... 
by Sophie Gilbert | May 21, 2021 | Alzheimer's Disease, Medical Officers
Current research on Alzheimer’s Disease (AD) suggests that it is the abnormal build-up of proteins like amyloids, which deposit plaques in and around brain cells, that lead to degeneration of cognitive function. Until recently, there was no evidence for any... 
by Smriti Haria | May 20, 2021 | Alzheimer's Disease, IV. Others, Medical Officers, Prescribers
According to the Mayo Clinic, around 5.8 million people over the age of 65 in the United States are diagnosed with Alzheimer’s Disease (AD) [1]. Neurons in the brain atrophy, leading to an impairment in thinking, cognitive and social skills. Additionally, AD is the... 
Recent Comments